Exploring the Influence of Different Albumin Binders on Molecular Imaging Probe Distribution.
Animals
Breast Neoplasms
/ metabolism
Female
Fibrosarcoma
/ metabolism
Fluorescent Dyes
/ chemistry
Humans
Mice
Mice, Nude
Molecular Imaging
/ methods
Molecular Probes
/ chemistry
Optical Imaging
Receptor, Endothelin A
/ chemistry
Serum Albumin
/ chemistry
Tissue Distribution
Tumor Cells, Cultured
Xenograft Model Antitumor Assays
albumin
bioavailability
endothelin receptors
fluorescence molecular imaging
tumor imaging
Journal
Molecular pharmaceutics
ISSN: 1543-8392
Titre abrégé: Mol Pharm
Pays: United States
ID NLM: 101197791
Informations de publication
Date de publication:
05 07 2021
05 07 2021
Historique:
pubmed:
29
5
2021
medline:
11
1
2022
entrez:
28
5
2021
Statut:
ppublish
Résumé
The biodistribution of molecular imaging probes or tracers mainly depends on the chemical nature of the probe and the preferred metabolization and excretion routes. Small molecules have rather short half-lives while antibodies reside inside the organism for a longer period of time. An excretion via kidneys and bladder is faster than a mainly hepatobiliary elimination. To manipulate the biodistribution behavior of probes, different strategies have been pursued, including utilizing serum albumin as an inherent transport mechanism for small molecules. Here, we modified an existing small molecular fluorescent probe targeted to the endothelin-A receptor (ET
Identifiants
pubmed: 34048242
doi: 10.1021/acs.molpharmaceut.1c00064
doi:
Substances chimiques
Fluorescent Dyes
0
Molecular Probes
0
Receptor, Endothelin A
0
Serum Albumin
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM